Structures by: Akkurt M.
Total: 604
1-{6-Chloro-2-[(2-chloro-6-methylquinolin-3-yl)methoxy]-4-phenylquinolin- 3-yl}ethanone
C28H20Cl2N2O2
Acta Crystallographica Section E (2010) 66, 7 o1693-o1694
a=8.0552(2)Å b=12.4499(5)Å c=13.3718(5)Å
α=67.555(4)° β=80.183(3)° γ=77.273(3)°
<i>N</i>-[(2<i>S</i>)-2-(4-Bromophenyl)-4-oxo-1,3-thiazolidin-3-yl]pyridine-3- carboxamide
C15H12BrN3O2S
Acta Crystallographica Section E (2010) 66, 7 o1691-o1692
a=24.9588(9)Å b=24.9588(9)Å c=12.8013(5)Å
α=90° β=90° γ=120°
<i>N</i>-(5-chloro-2-methoxyphenyl)benzenesulfonamide
C13H12ClNO3S
Acta Crystallographica Section E (2010) 66, 11 o2855
a=8.2201(2)Å b=8.9395(2)Å c=10.5544(2)Å
α=77.2060(10)° β=76.3660(10)° γ=66.4080(10)°
2,4,6-Trimethylpyridinium nitrate
C8H12N,NO3
Acta Crystallographica Section E (2010) 66, 9 o2362
a=9.3280(10)Å b=15.1327(13)Å c=6.4967(7)Å
α=90° β=90° γ=90°
1-(Prop-2-en-1-yl)-3-[(trimethylsilyl)methyl]benzimidazolium bromide monohydrate
C14H21N2Si,Br,H2O
Acta Crystallographica Section E (2010) 66, 9 o2393-o2394
a=8.9063(2)Å b=10.4720(2)Å c=10.9439(3)Å
α=66.542(4)° β=71.479(4)° γ=80.625(5)°
3,5-Bis(4-methylphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2
Acta Crystallographica Section E (2011) 67, 4 o1019
a=5.8113(3)Å b=10.6959(5)Å c=28.4455(13)Å
α=90° β=94.983(4)° γ=90°
1,3-Bis(3-phenylpropyl)-1<i>H</i>-benzimidazol-3-ium-2-carbodithioate
C26H26N2S2
Acta Crystallographica Section E (2009) 65, 1 o174-o175
a=27.2391(11)Å b=8.3483(4)Å c=10.3200(4)Å
α=90° β=90° γ=90°
2-[2-(2,6-Dichloroanilino)phenyl]-<i>N</i>'-(4- propylcyclohexylidene)acetohydrazide
C23H27Cl2N3O
Acta Crystallographica Section E (2010) 66, 2 o256-o257
a=13.0235(6)Å b=15.2618(5)Å c=26.6255(12)Å
α=90° β=118.098(3)° γ=90°
2-[(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>- pyrazol-4-yl)amino]-1-methyl-2-oxoethyl pyrrolidine-1-carbodithioate
C19H24N4O2S2
Acta Crystallographica Section E (2010) 66, 12 o3134-o3135
a=12.0652(5)Å b=16.0831(6)Å c=11.0438(4)Å
α=90° β=101.899(3)° γ=90°
<i>N</i>-(4-Methoxyphenyl)-4-methylbenzenesulfonamide
C14H15NO3S
Acta Crystallographica Section E (2011) 67, 1 o186
a=9.1777(4)Å b=5.2179(2)Å c=15.1621(7)Å
α=90° β=103.518(2)° γ=90°
2-{2-[4-(4-Fluorophenyl)piperazin-1-yl]-2-oxoethyl}-6-(morpholin-4-yl)- 4-phenylpyridazin-3(2<i>H</i>)-one
C26H28FN5O3
Acta Crystallographica Section E (2011) 67, 3 o666-o667
a=8.9168(5)Å b=10.7106(6)Å c=13.5147(8)Å
α=73.489(4)° β=71.309(4)° γ=83.486(4)°
2-(6-Benzoyl-2-oxo-1,3-benzothiazol-3-yl)acetic acid
C16H11NO4S
Acta Crystallographica Section E (2010) 66, 1 o168
a=11.4248(3)Å b=8.9155(2)Å c=27.6280(8)Å
α=90° β=90° γ=90°
2-Chloro-8-methyl-3-[(pyrimidin-4-yloxy)methyl]quinoline
C15H12ClN3O
Acta Crystallographica Section E (2010) 66, 5 o1010
a=11.9975(2)Å b=8.45037(15)Å c=12.95869(19)Å
α=90° β=96.7619(16)° γ=90°
5-(4-Chlorophenyl)-3-(2,4-dimethylthiazol-5-yl)-1,2,4- triazolo[3,4-<i>a</i>]isoquinoline
C21H15ClN4S
Acta Crystallographica Section E (2010) 66, 5 o1056-o1057
a=7.8286(5)Å b=8.1754(6)Å c=15.1264(9)Å
α=93.514(5)° β=94.805(5)° γ=105.963(6)°
<i>N</i>-Ethyl-<i>N</i>-(2-methoxyphenyl)benzenesulfonamide
C15H17NO3S
Acta Crystallographica Section E (2010) 66, 7 o1728
a=9.3098(5)Å b=9.5664(6)Å c=17.1949(10)Å
α=90° β=104.040(2)° γ=90°
1-Benzyl-3-[(trimethylsilyl)methyl]benzimidazolium chloride monohydrate
C18H23N2Si,Cl,H2O
Acta Crystallographica Section E (2010) 66, 7 o1770-o1771
a=9.3592(7)Å b=10.9500(9)Å c=11.0522(8)Å
α=117.594(6)° β=103.295(6)° γ=92.094(6)°
1-{6-Chloro-2-[(2-chloro-3-quinolyl)methoxy]-4-phenyl-3-quinolyl}ethan-1-one
C27H18Cl2N2O2
Acta Crystallographica Section E (2010) 66, 7 o1607-o1608
a=9.2694(3)Å b=10.8862(4)Å c=13.0490(5)Å
α=100.615(3)° β=103.570(3)° γ=111.894(4)°
3-[(2-Chloro-6-methylquinolin-3-yl)methyl]quinazolin-4(3<i>H</i>)-one
C19H14ClN3O
Acta Crystallographica Section E (2010) 66, 7 o1545
a=7.86728(14)Å b=14.7098(3)Å c=13.7055(3)Å
α=90° β=102.1500(17)° γ=90°
(2-Chloro-8-methoxyquinolin-3-yl)methanol monohydrate
C11H10ClNO2,H2O
Acta Crystallographica Section E (2010) 66, 7 o1542
a=9.161(5)Å b=14.246(5)Å c=9.464(5)Å
α=90° β=116.819(5)° γ=90°
(2-Chloro-8-methylquinolin-3-yl)methanol
C11H10ClNO
Acta Crystallographica Section E (2010) 66, 7 o1543
a=14.963(2)Å b=4.6320(10)Å c=14.469(2)Å
α=90° β=103.6120(10)° γ=90°
(2-Chloro-6-methylquinolin-3-yl)methanol
C11H10ClNO
Acta Crystallographica Section E (2010) 66, 7 o1544
a=14.8091(17)Å b=4.6387(5)Å c=14.5098(11)Å
α=90° β=96.594(9)° γ=90°
Ammonium [(1<i>S</i>)-(<i>endo</i>,<i>anti</i>)]-(-)-3-bromocamphor-8-sulfonate
H4N,C10H14BrO4S
Acta Crystallographica Section E (2010) 66, 7 o1707-o1708
a=7.2449(2)Å b=7.00490(10)Å c=13.2428(3)Å
α=90° β=104.7040(10)° γ=90°
1-Chloromethyl-4-nitrobenzene
C7H6ClNO2
Acta Crystallographica Section E (2010) 66, 7 o1667
a=4.74340(10)Å b=6.4189(2)Å c=24.9413(11)Å
α=90° β=90° γ=90°
<i>N</i>-{[4-(4-Methoxybenzenesulfonamido)phenyl]sulfonyl}acetamide
C15H16N2O6S2
Acta Crystallographica Section E (2010) 66, 7 o1768
a=5.3651(10)Å b=20.551(3)Å c=15.034(2)Å
α=90° β=94.040(7)° γ=90°
<i>N</i>-(2-Methoxyphenyl)benzenesulfonamide
C13H13NO3S
Acta Crystallographica Section E (2010) 66, 7 o1769
a=8.7705(2)Å b=28.1684(7)Å c=10.7256(3)Å
α=90° β=105.9680(10)° γ=90°
<i>N</i>-{4-[(5-Methylisoxazol-3-yl)sulfamoyl]phenyl}benzamide
C17H15N3O4S
Acta Crystallographica Section E (2010) 66, 9 o2264
a=8.2407(6)Å b=23.5069(16)Å c=8.5199(6)Å
α=90° β=92.155(3)° γ=90°
1-(4-Methoxyphenyl)-4-(4-methylphenyl)-3-phenoxyazetidin-2-one
C23H21NO3
Acta Crystallographica Section E (2011) 67, 2 o326-o327
a=6.0764(3)Å b=9.9545(5)Å c=16.4519(10)Å
α=104.360(4)° β=91.261(5)° γ=97.724(4)°
<i>N</i>-{4-[(2-Methoxyphenyl)sulfamoyl]phenyl}acetamide
C15H16N2O4S
Acta Crystallographica Section E (2011) 67, 2 o303-o304
a=15.7277(4)Å b=11.8351(3)Å c=16.5247(4)Å
α=90° β=90° γ=90°
<i>N</i>-[5-Methyl-2-(2-nitrophenyl)-4-oxo-1,3-thiazolidin-3-yl]pyridine-3- carboxamide monohydrate
C16H14N4O4S,H2O
Acta Crystallographica Section E (2011) 67, 2 o293-o294
a=8.1399(4)Å b=8.4106(4)Å c=15.0274(7)Å
α=92.957(4)° β=104.176(4)° γ=116.792(4)°
4-(2-Methoxybenzylidene)-2-phenyl-1,3-oxazol-5(4<i>H</i>)-one
C17H13NO3
Acta Crystallographica Section E (2009) 65, 4 o842
a=8.8073(6)Å b=9.6140(6)Å c=9.8272(6)Å
α=66.503(4)° β=67.248(4)° γ=71.734(4)°
3,4-Dimethoxy-<i>N</i>-(4-nitrobenzylidene)aniline
C15H14N2O4
Acta Crystallographica Section E (2008) 64, 11 o2087
a=7.9536(4)Å b=8.2258(3)Å c=21.3418(10)Å
α=90° β=96.125(4)° γ=90°
Bis(phenanthridinium) hexachloridoplatinate(IV) dimethyl sulfoxide disolvate
2(C13H10N),Cl6Pt2,2(C2H6OS)
Acta Crystallographica Section E (2009) 65, 2 m235
a=24.3695(11)Å b=7.9061(3)Å c=17.4322(6)Å
α=90° β=90° γ=90°
4-(9-Anthryl)-1-phenylspiro[azetidine-3,9'-xanthen]-2-one
C35H23NO2
Acta Crystallographica Section E (2009) 65, 3 o501-o502
a=13.6906(8)Å b=13.3085(7)Å c=17.3527(10)Å
α=90° β=127.548(4)° γ=90°
C36H25NO3
C36H25NO3
Acta Crystallographica Section E (2009) 65, 3 o626-o627
a=11.8496(3)Å b=15.3168(5)Å c=14.9883(4)Å
α=90° β=106.536(2)° γ=90°
Ethyl (<i>Z</i>)-2-cyano-3-(9-ethyl-9<i>H</i>-carbazol-3-yl)prop-2-enoate
C20H18N2O2
Acta Crystallographica Section E (2009) 65, 5 o1169
a=10.8030(7)Å b=13.4443(10)Å c=11.6160(7)Å
α=90° β=93.387(5)° γ=90°
2-[(<i>E</i>)-2,5-Dimethoxybenzylidene]indan-1-one
C18H16O3
Acta Crystallographica Section E (2009) 65, 5 o1061
a=12.925(3)Å b=20.163(5)Å c=5.4510(10)Å
α=90° β=90° γ=90°
2,9-Dimethyl-4,7-diphenyl-1,10-phenanthrolin-1-ium tetrachloridoaurate(III)
C26H21N2,AuCl4
Acta Crystallographica Section E (2009) 65, 5 m479-m480
a=13.5195(10)Å b=22.9565(17)Å c=7.5556(6)Å
α=90° β=90° γ=90°
2-[3-(2-Pyridyl)pyrazin-2-yl]pyridinium tetrachloridoaurate(III)
C14H11N4,AuCl4
Acta Crystallographica Section E (2009) 65, 5 m491-m492
a=7.4098(6)Å b=15.5188(13)Å c=14.6197(12)Å
α=90° β=90.3800(10)° γ=90°
<i>N</i>'-[(2<i>Z</i>)-3-Allyl-4-oxo-1,3-thiazolidin-2-ylidene]-5-fluoro- 3-phenyl-1<i>H</i>-indole-2-carbohydrazide
C21H17FN4O2S
Acta Crystallographica Section E (2009) 65, 5 o1009-o1010
a=21.9754(6)Å b=14.7215(5)Å c=16.2447(4)Å
α=90° β=132.022(2)° γ=90°
2-Benzenesulfonamidobenzoic acid
C13H11NO4S
Acta Crystallographica Section E (2009) 65, 6 o1246-o1247
a=27.271(3)Å b=8.7223(9)Å c=11.0077(10)Å
α=90° β=106.149(3)° γ=90°
1,4-Bis(methylsulfanyl)naphthalene
C12H12S2
Acta Crystallographica Section E (2009) 65, 6 o1376
a=15.203(3)Å b=10.246(2)Å c=7.1750(14)Å
α=90° β=99.43(3)° γ=90°
(E)-2-Cyano-3-[4-(dimethylamino)phenyl]-<i>N</i>-phenylprop-2-enamide
C18H17N3O
Acta Crystallographica Section E (2009) 65, 6 o1303
a=12.0639(19)Å b=19.983(3)Å c=6.3960(9)Å
α=90° β=94.870(6)° γ=90°
(+-)-<i>trans</i>-6,7-Dimethoxy-1-oxo-3-(2-thienyl)isochroman-4-carboxylic acid
C16H14O6S
Acta Crystallographica Section E (2009) 65, 6 o1377
a=8.3369(6)Å b=8.4587(6)Å c=11.9143(9)Å
α=76.441(6)° β=81.127(6)° γ=72.958(6)°
Methyl <i>trans</i>-(+-)-1-oxo-2-phenethyl-3-(thiophen-2-yl)-1,2,3,4- tetrahydroisoquinoline-4-carboxylate
C23H21NO3S
Acta Crystallographica Section E (2009) 65, 6 o1287-o1288
a=8.8841(3)Å b=30.7095(13)Å c=7.5757(3)Å
α=90° β=105.472(3)° γ=90°
4-(9-Anthryl)-1-(2,4-dimethoxyphenyl)spiro[azetidine-3,9'-xanthen]-2-one
C37H27NO4
Acta Crystallographica Section E (2009) 65, 7 o1623-o1624
a=12.3164(6)Å b=13.1277(7)Å c=18.4838(11)Å
α=92.434(5)° β=109.236(4)° γ=91.357(4)°
1,3-Difurfurylbenzimidazolium chloride monohydrate
C17H15N2O2.Cl,H2O
Acta Crystallographica Section E (2009) 65, 8 o2037-o2038
a=9.0201(5)Å b=9.3135(5)Å c=11.2711(6)Å
α=66.778(4)° β=81.869(4)° γ=73.656(4)°
4-(Methylamino)benzoic acid
C8H9NO2
Acta Crystallographica Section E (2009) 65, 10 o2574
a=5.0456(3)Å b=36.339(2)Å c=12.6496(5)Å
α=90° β=96.129(4)° γ=90°
4-(9-Anthryl)-1-(3-bromophenyl)spiro[azetidine-3,9'-xanthen]-2-one
C35H22BrNO2
Acta Crystallographica Section E (2009) 65, 10 o2522-o2523
a=11.1143(4)Å b=19.9412(5)Å c=14.0317(5)Å
α=90° β=122.106(2)° γ=90°
6-Hydroxymethyl-4-methoxy-2<i>H</i>-pyran-2-one
C7H8O4
Acta Crystallographica Section E (2010) 66, 1 o199
a=4.0499(5)Å b=18.101(2)Å c=9.4743(13)Å
α=90° β=96.720(7)° γ=90°
7-Benzenesulfonamido-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene- 2-carboxylic acid monohydrate
C14H14N2O5S2,H2O
Acta Crystallographica Section E (2010) 66, 1 o73-o74
a=5.9535(7)Å b=15.8248(19)Å c=18.411(2)Å
α=90° β=90° γ=90°
5-Chlorobenzothiazole-2-spiro-3'-indolin-2'-one
C14H9ClN2OS
Acta Crystallographica Section E (2010) 66, 2 o399-o400
a=12.8421(6)Å b=9.1159(3)Å c=22.1553(9)Å
α=90° β=97.051(3)° γ=90°
Dichloridobis[5-nitro-1-trimethylsilylmethyl-1<i>H</i>-benzimidazole- κ<i>N</i>^3^]cobalt(II) <i>N</i>,<i>N</i>-dimethylformamide solvate
C22H30Cl2CoN6O4Si2,C3H7NO
Acta Crystallographica Section E (2010) 66, 3 m253-m254
a=9.8982(4)Å b=11.6936(5)Å c=15.9293(6)Å
α=106.041(2)° β=107.408(2)° γ=99.040(3)°
4-Methyl-<i>N</i>-(4-methylphenyl)benzenesulfonamide
C14H15NO2S
Acta Crystallographica Section E (2010) 66, 4 o786
a=8.6419(8)Å b=8.8016(8)Å c=9.2509(7)Å
α=88.187(4)° β=77.010(4)° γ=74.812(4)°
5-Fluoro-<i>N</i>'-[(<i>E</i>)-4-methoxybenzylidene]-3-phenyl- 1<i>H</i>-indole-2-carbohydrazide
C23H18FN3O2
Acta Crystallographica Section E (2010) 66, 4 o830
a=19.5709(11)Å b=5.1546(2)Å c=24.3584(14)Å
α=90° β=127.686(3)° γ=90°
2-[2-(2,6-Dichloroanilino)phenyl]-<i>N</i>-[(2<i>S</i>)-2-methyl-3-oxo- 8-phenyl-1-thia-4-azaspiro[4.5]dec-4-yl]acetamide
C29H29Cl2N3O2S
Acta Crystallographica Section E (2010) 66, 4 o882
a=11.6105(6)Å b=24.3130(12)Å c=9.8137(5)Å
α=90° β=95.335(2)° γ=90°
4-{3-[Hydroxy(phenyl)methyl]-5-thioxo-4,5-dihydro-1<i>H</i>-1,2,4- triazol-4-yl}benzenesulfonamide
C15H14N4O3S2
Acta Crystallographica Section E (2010) 66, 4 o974-o975
a=8.2498(5)Å b=13.5167(7)Å c=14.2522(7)Å
α=90° β=90° γ=90°
Ethyl 6-chloro-2-[(2-chloro-7,8-dimethylquinolin-3-yl)methoxy]-4- phenylquinoline-3-carboxylate
C30H24Cl2N2O3
Acta Crystallographica Section E (2010) 66, 4 o972-o973
a=8.3187(5)Å b=28.0038(17)Å c=11.2093(7)Å
α=90° β=98.721(6)° γ=90°
<i>N</i>-[4-(<i>N</i>-Cyclohexylsulfamoyl)phenyl]acetamide
C14H20N2O3S
Acta Crystallographica Section E (2010) 66, 4 o868-o869
a=14.6929(19)Å b=13.3486(19)Å c=7.9769(12)Å
α=90° β=102.387(7)° γ=90°
1-[(2-Chloro-7-methyl-3-quinolyl)methyl]pyridin-2(1<i>H</i>)-one
C16H13ClN2O
Acta Crystallographica Section E (2010) 66, 4 o960
a=11.8934(3)Å b=11.1092(3)Å c=21.2858(6)Å
α=90° β=102.413(3)° γ=90°
1-[(2-Chloro-7,8-dimethylquinolin-3-yl)methyl]pyridin-2(1<i>H</i>)-one
C17H15ClN2O
Acta Crystallographica Section E (2010) 66, 4 o1001
a=7.07034(17)Å b=15.4729(4)Å c=13.1704(3)Å
α=90° β=96.342(2)° γ=90°
3-(4-Chlorophenyl)-5-phenyl-1,2,4-triazolo[3,4-<i>a</i>]isoquinoline
C22H14ClN3
Acta Crystallographica Section E (2010) 66, 5 o1094
a=7.9841(3)Å b=9.0679(4)Å c=23.9881(11)Å
α=90° β=93.078(4)° γ=90°
1-[(2-Chloro-8-methylquinolin-3-yl)methyl]pyridin-2(1<i>H</i>)-one
C16H13ClN2O
Acta Crystallographica Section E (2010) 66, 5 o1049
a=10.1513(2)Å b=9.3917(2)Å c=14.1430(2)Å
α=90° β=90.948(2)° γ=90°
5-(4-Chlorophenyl)-3-(2-furyl)-1,2,4-triazolo[3,4-<i>a</i>]isoquinoline
C20H12ClN3O
Acta Crystallographica Section E (2010) 66, 5 o1061
a=9.0281(9)Å b=12.6034(11)Å c=14.6444(15)Å
α=90° β=90° γ=90°
C23H14N4
C23H14N4
Acta Crystallographica Section E (2010) 66, 5 o1081
a=7.1614(3)Å b=18.0957(7)Å c=26.4021(9)Å
α=90.0° β=90.0° γ=90.0°
4-[(2<i>E</i>)-2-(4-Chlorobenzylidene)hydrazinylidene]-1-methyl- 1,4-dihydropyridine monohydrate
C13H12ClN3,H2O
Acta Crystallographica Section E (2010) 66, 6 o1324-o1325
a=5.8492(4)Å b=20.3101(10)Å c=12.2035(7)Å
α=90° β=113.855(4)° γ=90°
(2-Acetamido-5-chlorophenyl)(2-chlorophenyl)methanone
C15H11Cl2NO2
Acta Crystallographica Section E (2010) 66, 6 o1434
a=11.1371(11)Å b=5.0661(6)Å c=25.594(3)Å
α=90° β=100.672(9)° γ=90°
Methyl 1-methyl-1<i>H</i>-1,2,3-triazole-4-carboxylate
C5H7N3O2
Acta Crystallographica Section E (2010) 66, 6 o1468
a=5.6970(10)Å b=7.1314(11)Å c=8.6825(16)Å
α=71.053(16)° β=86.865(15)° γ=76.528(14)°
<i>N</i>-(3-Ethoxyphenyl)-4-methylbenzenesulfonamide
C15H17NO3S
Acta Crystallographica Section E (2010) 66, 7 o1682
a=8.4612(3)Å b=13.1862(5)Å c=13.4237(4)Å
α=90° β=99.326(2)° γ=90°
2-Amino-1,3-benzothiazol-3-ium dihydrogen phosphate
C7H7N2S,H2O4P
Acta Crystallographica Section E (2010) 66, 8 o1929
a=12.3915(4)Å b=10.1572(3)Å c=8.3159(2)Å
α=90° β=103.7750(10)° γ=90°
2,4-Dichloro-7,8-dimethylquinoline
C11H9Cl2N
Acta Crystallographica Section E (2010) 66, 7 o1535
a=20.3054(9)Å b=3.9992(2)Å c=25.5743(11)Å
α=90° β=90° γ=90°
2-Chloro-<i>N</i>-(4-sulfamoylphenyl)acetamide
C8H9ClN2O3S
Acta Crystallographica Section E (2010) 66, 7 o1596
a=4.7870(2)Å b=14.1868(9)Å c=16.0158(9)Å
α=90° β=90.907(4)° γ=90°
Hexakis(thiourea-κ<i>S</i>)nickel(II) nitrate
C6H24N12NiS62,2(NO3)
Acta Crystallographica Section E (2010) 66, 8 i57-i58
a=22.4433(6)Å b=9.2398(3)Å c=16.3136(5)Å
α=90° β=129.7240(10)° γ=90°
[2,3,7,8,13,14,17,18-Octakis(ethylsulfanyl)-5,10,15,20-porphyrazinato]zinc(II)
C32H40N8S8Zn
Acta Crystallographica Section E (2010) 66, 8 m998-m999
a=8.79730(10)Å b=27.2813(3)Å c=32.0903(6)Å
α=90° β=90° γ=90°
1-{6-Chloro-2-[(2-chloro-8-methyl-3-quinolyl)methoxy]-4-phenylquinolin- 3-yl}ethanone
C28H20Cl2N2O2
Acta Crystallographica Section E (2010) 66, 8 o1930
a=9.7396(4)Å b=10.5520(3)Å c=13.0108(4)Å
α=88.730(3)° β=68.127(4)° γ=71.105(4)°
<i>N</i>-[2-(4-Methyl-2-quinolyl)phenyl]acetamide
C18H16N2O
Acta Crystallographica Section E (2010) 66, 8 o2043-o2044
a=9.7383(5)Å b=9.9035(6)Å c=15.2809(9)Å
α=101.414(5)° β=99.188(5)° γ=90.065(5)°
1-(3,5-Diethyl-1<i>H</i>-pyrazol-1-yl)-3-phenylisoquinoline
C22H21N3
Acta Crystallographica Section E (2010) 66, 8 o2063-o2064
a=16.0736(17)Å b=20.819(2)Å c=10.8579(11)Å
α=90° β=91.071(3)° γ=90°
6,8-Dibromoquinoline
C9H5Br2N
Acta Crystallographica Section E (2010) 66, 11 o2997-o2998
a=7.3436(12)Å b=9.8961(15)Å c=13.0108(18)Å
α=90° β=109.589(17)° γ=90°
<i>N</i>-Benzyl-<i>N</i>-(2-methoxyphenyl)benzenesulfonamide
C20H19NO3S
Acta Crystallographica Section E (2010) 66, 11 o2980
a=10.0368(3)Å b=9.0176(3)Å c=20.4228(7)Å
α=90° β=103.424(2)° γ=90°
5-Bromo-2-hydroxybenzaldehyde thiosemicarbazone
C8H8BrN3OS
Acta Crystallographica Section E (2010) 66, 11 o2999
a=4.4564(2)Å b=8.3515(3)Å c=27.7153(14)Å
α=90° β=90° γ=90°
5-Chloro-2-hydroxybenzaldehyde thiosemicarbazone
C8H8ClN3OS
Acta Crystallographica Section E (2010) 66, 11 o2981
a=5.8303(4)Å b=23.6579(17)Å c=7.5893(5)Å
α=90° β=104.164(6)° γ=90°
<i>N</i>-(2-Hydroxy-1,1-dimethylethyl)benzenesulfonamide
C10H15NO3S
Acta Crystallographica Section E (2010) 66, 11 o3028
a=12.4094(3)Å b=9.0042(2)Å c=10.4525(2)Å
α=90° β=93.7310(10)° γ=90°
<i>N</i>'-[(<i>E</i>)-2-Hydroxy-5-methoxybenzylidene]pyridine-4-carbohydrazide
C14H13N3O3
Acta Crystallographica Section E (2010) 66, 11 o2982
a=6.1114(6)Å b=29.489(3)Å c=7.4820(7)Å
α=90° β=96.696(8)° γ=90°
3,6,8-Tribromoquinoline
C9H4Br3N
Acta Crystallographica Section E (2010) 66, 12 o3133
a=3.9810(2)Å b=12.4176(4)Å c=19.7419(6)Å
α=90° β=92.827(3)° γ=90°
<i>N</i>-Benzyl-<i>N</i>,4-dimethylbenzenesulfonamide
C15H17NO2S
Acta Crystallographica Section E (2010) 66, 12 o3053
a=15.0386(16)Å b=8.2632(7)Å c=12.0758(12)Å
α=90° β=105.902(4)° γ=90°
2-[(<i>E</i>)-(4-Methylphenyl)iminomethyl]-6-(morpholin-4-ylmethyl)phenol
C19H22N2O2
Acta Crystallographica Section E (2011) 67, 1 o147-o148
a=9.807(3)Å b=10.091(3)Å c=10.528(3)Å
α=99.78(2)° β=109.34(2)° γ=115.18(2)°
2-[6-(4-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3]thiazol-2-yl]- <i>N</i>'-[(<i>E</i>)-4-methoxybenzylidene]acetohydrazide
C21H17ClN4O2S
Acta Crystallographica Section E (2011) 67, 1 o184-o185
a=13.4591(6)Å b=4.7834(3)Å c=30.4674(14)Å
α=90° β=90° γ=90°
3-(2,4-Dichlorophenoxy)-1-(4-methoxyphenyl)-4-(3-nitrophenyl)azetidin-2-one
C22H16Cl2N2O5
Acta Crystallographica Section E (2011) 67, 1 o183
a=9.0406(2)Å b=17.8177(5)Å c=25.9964(6)Å
α=90° β=90° γ=90°
3,5-Bis(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2O2
Acta Crystallographica Section E (2011) 67, 2 o328-o329
a=9.4788(5)Å b=10.1893(6)Å c=19.9139(10)Å
α=90° β=92.296(4)° γ=90°
<i>N</i>-(2-Hydroxy-1,1-dimethylethyl)-4-methylbenzenesulfonamide
C11H17NO3S
Acta Crystallographica Section E (2011) 67, 2 o295
a=10.4870(3)Å b=9.0760(3)Å c=13.4930(5)Å
α=90° β=97.755(2)° γ=90°
2-Ethyl-2,3-dihydro-1,2-benzothiazole-1,1,3-trione
C9H9NO3S
Acta Crystallographica Section E (2011) 67, 4 o887
a=10.4559(5)Å b=7.5484(5)Å c=12.9408(7)Å
α=90° β=105.863(2)° γ=90°
2-(4-Chlorobenzamido)acetic acid
C9H8ClNO3
Acta Crystallographica Section E (2011) 67, 4 o916
a=10.5035(2)Å b=13.2105(4)Å c=7.1226(2)Å
α=90° β=102.2030(10)° γ=90°
<i>N</i>-[2-(4-Bromophenyl)-5-methyl-4-oxo-1,3-thiazolidin-3-yl]pyridine-3- carboxamide
C16H14BrN3O2S
Acta Crystallographica Section E (2011) 67, 4 o914-o915
a=24.5799(8)Å b=24.5799(8)Å c=10.9601(6)Å
α=90° β=90° γ=90°
<i>N</i>-Cyclohexyl-4-methoxybenzenesulfonamide
C13H19NO3S
Acta Crystallographica Section E (2011) 67, 4 o885-o886
a=17.2644(12)Å b=20.4707(16)Å c=7.9139(5)Å
α=90° β=90° γ=90°
<i>N</i>-[2-(4-Chlorophenyl)-5-methyl-4-oxo-1,3-thiazolidin-3-yl]pyridine-3- carboxamide
C16H14ClN3O2S
Acta Crystallographica Section E (2011) 67, 4 o745-o746
a=11.4481(7)Å b=12.0276(7)Å c=12.5556(7)Å
α=91.798(5)° β=100.282(5)° γ=98.068(5)°
5-Chloro-<i>N</i>-(4,5-dihydro-1<i>H</i>-imidazol-2-yl)-2,1,3-benzothiadiazol- 4-amine
C9H8ClN5S
Acta Crystallographica Section E (2011) 67, 4 o838-o839
a=7.6927(3)Å b=10.8558(4)Å c=12.9969(5)Å
α=95.7900(10)° β=101.1260(10)° γ=92.1920(10)°
(2<i>E</i>)-3-[4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)phenyl]- 1-(4-methoxyphenyl)prop-2-en-1-one
C24H20N2O3
Acta Crystallographica Section E (2011) 67, 5 o1088-o1089
a=7.2244(5)Å b=9.3201(8)Å c=14.9422(9)Å
α=98.449(2)° β=99.183(4)° γ=99.478(4)°
1,3-Bis(3-phenylpropyl)-1<i>H</i>-1,3-benzimidazole-2(3<i>H</i>)-selone
C25H26N2Se
Acta Crystallographica Section E (2011) 67, 5 o1179
a=10.5150(3)Å b=10.5150(3)Å c=19.8142(8)Å
α=90° β=90° γ=90°
3-(4-Chlorophenoxy)-1-(4-methoxyphenyl)-4-(4-nitrophenyl)azetidin-2-one
C22H17ClN2O5
Acta Crystallographica Section E (2011) 67, 5 o1101-o1102
a=6.0863(2)Å b=20.0855(7)Å c=17.3819(7)Å
α=90° β=97.419(4)° γ=90°
<i>N</i>-[4-(Propylsulfamoyl)phenyl]acetamide
C11H16N2O3S
Acta Crystallographica Section E (2012) 68, 2 o290-o291
a=8.7791(6)Å b=14.1747(11)Å c=20.1577(14)Å
α=90° β=90° γ=90°
1-(2-Hydroxyethyl)-4-[3-(2-trifluoromethyl-9<i>H</i>-thioxanthen-9- ylidene)propyl]piperazine-1,4-diium dichloride
C23H27F3N2OS2,2(Cl)
Acta Crystallographica Section E (2011) 67, 8 o2079-o2080
a=34.1750(17)Å b=7.1613(3)Å c=22.6351(11)Å
α=90° β=115.307(6)° γ=90°